Physician profile
Maaz Iqbal
NPI 1760778906
$10,273.42
in general payments reported to CMS, 2019-2025
22 companies · $848 in 2025
The $848 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,381 · 2020: $1,235 · 2021: $1,615 · 2022: $1,515 · 2023: $1,771 · 2024: $1,908 · 2025: $848.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,189 · Travel and Lodging: $338.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,189.14 |
| Travel and Lodging | $337.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $5,820.38 | 2019-2025 | Proclaim, Eterna |
| Nevro Corp. | $1,189.71 | 2019-2024 | Senza |
| Boston Scientific Corporation | $777.24 | 2019-2024 | |
| Medtronic, INC. | $651.64 | 2022-2025 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray, Inceptiv |
| Saluda Medical Americas, INC. | $493.15 | 2024 | Evoke |
| Spr Therapeutics, INC | $414.89 | 2023 | Sprint Pns System |
| Spinal Simplicity, LLC | $193.56 | 2024-2025 | Ha Minuteman G3-R |
| Sirtex Medical INC | $144.60 | 2024 | Sir-Spheres Microspheres |
| Painteq LLC | $104.25 | 2023-2024 | Painteq |
| Vertiflex, INC. | $94.37 | 2019 | |
| Medtronic USA, INC. | $75.86 | 2020 | |
| Globus Medical, INC. | $55.98 | 2025 | Senza |
| Fidia Pharma USA INC. | $55.13 | 2022 | |
| Curonix LLC | $46.39 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Ekos Corporation | $33.10 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Electronic Waveform Lab, INC. | $29.35 | 2024 | |
| Bioventus LLC | $24.51 | 2024 | Supartz Fx Sodium Hyaluronate |
| Amgen INC. | $18.30 | 2019 | |
| International Rehabilitative Sciences, INC | $14.78 | 2024 | Rs 4i Plus Sequential Stimulator |
| Novartis Pharmaceuticals Corporation | $12.78 | 2020 | |
| Zyla Life Sciences, INC. | $11.88 | 2020 | |
| Pfizer INC. | $11.57 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maaz Iqbal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.